Beyond these Aβ-related effects, cross-sectional neuroimaging studies have also demonstrated higher tau burden in individuals with depressive symptoms (Gatchel et al., 2017), raising the possibility that depression may be linked not only to Aβ burden but also to tau pathology. This evidence concerns the gene MAPT and major depressive disorder.